drugset / Trial / NCT01569126

A Study of LY110140 in Healthy Japanese Male Participants

NCT01569126

Phase 1 Completed 56 enrolled Eli Lilly and Company
RandomizedParallel-groupQuadruple-blindBasic science

Summary

The purposes of this study are to look at safety, how well the study drug (LY110140) is tolerated, and how much of the study drug gets into the blood stream when given as single dose (SD) and multiple doses (MD) to healthy Japanese male participants. Participants will participate in SD portion for approximately 6 weeks and in MD portion for approximately 10 weeks.

Timeline

Start
2012-04
Primary completion
2012-09
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluoxetine Small molecule 5 mg Oral
Subject Fluoxetine Small molecule 20 mg Oral
Subject Fluoxetine Small molecule 40 mg Oral

Indications

No indication recorded.